PLEKHM2-ALK: A novel fusion in small-cell lung cancer and durable response to ALK inhibitors

Li, T; Zhang, F; Wu, ZZ; Cui, LG; Zhao, XC; Wang, JL; Hu, Y

Hu, Y (corresponding author), Peoples Liberat Army Gen Hosp, PLA Sch Med, Dept Oncol, 28 Fuxing Rd, Beijing 100853, Peoples R China.

LUNG CANCER, 2020; 139 (): 146

Abstract

Objectives: In non-small cell lung cancer (NSCLC), anaplastic lymphoma kinase (ALK) rearrangement identifies a subgroup of patients who are sensitive ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索